|
|
Article: Protein Pathways Lands Merck In First Technology Partnership.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
Protein Pathways Inc. hasn't been on the drug discovery trail for long, but a recent endorsement is helping to map out its near-term future.
The Woodland Hills, Calif.-based company is being commissioned by Merck & Co. Inc., which plans to use Protein Pathways' ProNexus drug discovery technology in its own research efforts. The technology is designed to help researchers negotiate the sometimes-foggy cellular pathways. ProNexus works to predict, integrate and analyze protein interactions from multiple data sources to identify therapeutically relevant genes in specific disease pathways.
"This demonstrates that a company like Merck ...